FDA clears GE's AdreView imaging agent
Article Thumbnail ImageSeptember 19, 2008 -- GE Healthcare of Chalfont St. Giles, U.K., has received clearance from the U.S. Food and Drug Administration (FDA) to market its AdreView (iobenguane I-123 injection) molecular imaging agent for the detection of rare neuroendocrine tumors in children and adults.
Member Sign In:
  MemberID or E-mail Address:

New AuntMinnie.com Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • Online CME
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • The FDA's ruling comes after the agency designated AdreView for priority review in June.

    AdreView is designed to aid in the diagnostic assessment of pediatric cancer patients with neuroblastoma, the most common extracranial solid tumor in young children up to five years of age. It's also indicated for pheochromocytoma, a rare tumor that typically affects adults.

    Both tumors usually arise from tissues of the sympathetic nervous system, most commonly in the adrenal glands. The tumors can be difficult to detect at an early stage because symptoms may be nonspecific when the tumors are small.

    AdreView images reflect the functional behavior of tumor cells, thus allowing clearer characterization of small tumors in comparison to similar-appearing, but nonmalignant, tissues. AdreView's information is intended to complement anatomic imaging procedures, such as CT, MRI, and SPECT.

    GE noted that AdreView also will permit imaging of these tumors with a lower radiation dose than other agents that have been available for the same purpose.

    The company plans to begin shipping AdreView to hospitals and imaging centers in the U.S. in the coming weeks.

    Related Reading

    GE upgrades PACS-IW software, September 17, 2008

    GE inks 7-telsa MRI deal with Varian, September 15, 2008

    GE shows new Centricity product, September 11, 2008

    GE debuts new ultrasound scanner, September 5, 2008

    GE debuts ob/gyn US upgrades, August 27, 2008

    Copyright © 2008 AuntMinnie.com

    || About || Advertising || AuntMinnieCME.com || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2014 || Education || Equipment Classifieds || Europe || Facebook || Forums || Home || Links || Marketplace || Middle East || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2013 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2014 AuntMinnie.com. All Rights Reserved.